Tachycardia in adults with cystic fibrosis is associated with normal autonomic function

Internal Medicine Journal

Volumn 41, Issue 6, 2011, Pages 455-461

  Szollosi, I ^a   King, S J ^b,c   Wilson, J W ^a   Naughton, M T ^a  

^a Department of Allergy Immunology and Respiratory Medicine ^*  (Australia)

^b ALFRED HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Autonomic function; Cystic fibrosis; Tachycardia

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM FUNCTION; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE VARIABILITY; HUMAN; MALE; PRIORITY JOURNAL; SPIROMETRY; TACHYCARDIA;

ADULT; AUTONOMIC NERVOUS SYSTEM; CYSTIC FIBROSIS; DIABETES COMPLICATIONS; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; RESPIRATORY MECHANICS; TACHYCARDIA; YOUNG ADULT;

EID: 79959594580     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.02039.x     Document Type: Article

References (38)

1. Welsh M, Boat T, Tsui L, Beaudet A. Cystic fibrosis. In: Scriver C, Beaudet A, Sly W, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease, 1995 edn. New York: McGraw-Hill; 1995; 3799-876.
2. Cystic Fibrosis Foundation Patient Registry. Cystic Fibrosis Foundation Patient Registry Annual Data Report 2006. Bethesda, MD: Cystic Fibrosis Foundation Patient Registry; 2007. [Cited 2009 Sep 14]. Available from URL:
3. Bentur L, Hino B, Shamir R, Elias N, Hartman C, Eshach-Adiv O etal. Impaired gastric myoelectrical activity in patients with cystic fibrosis. J Cyst Fibros 2006; 5: 187-91.
4. Davis P, Shelhamer J, Kaliner M. Abnormal adrenergic and cholinergic sensitivity in cystic fibrosis. N Engl J Med 1980; 302: 1453-6.
5. Smith SA, Smith SE. Evidence for a neuropathic aetiology in the small pupil of diabetes mellitus. Br J Ophthalmol 1983; 67: 89-93.
6. Brennan AL, Geddes DM, Gyi KM, Baker EH. Clinical importance of cystic fibrosis-related diabetes. J Cyst Fibros 2004; 3: 209-22.
7. Mackie ADR, Thornton SJ, Edenborough FP. Cystic fibrosis-related diabetes. Diabet Med 2003; 20: 425-36.
8. Moran A. Diagnosis, screening, and management of cystic fibrosis-related diabetes. Curr Diab Rep 2002; 2: 111-15.
9. Westall GP, Binder J, Kotsimbos T, Topliss D, Thomson N, Dowling J etal. Nodular glomerulosclerosis in cystic fibrosis mimics diabetic nephropathy. Nephron Clin Pract 2004; 96: c70-5.
10. Serizawa T, Vogel WM, Apstein CS, Grossman W. Comparison of acute alterations in left ventricular relaxation and diastolic chamber stiffness induced by hypoxia and ischemia. Role of myocardial oxygen supply-demand imbalance. J Clin Invest 1981; 68: 91-102.
11. Cargill RI, Keily DG, Lipworth BJ. Adverse effects of hypoxemia on diastolic filling in humans. Clin Sci (Lond) 1995; 89: 165-9.
12. Kannel WB, Kannel C, Paffenbarger RS, Cupples PH, Cupples LA. Heart rate and cardiovascular mortality: the Framingham study. Am Heart J 1987; 113: 1489-94.
13. Bradley S, Solin P, Wilson J, Johns D, Walters EH, Naughton MT. Hypoxemia and hypercapnia during exercise and sleep in patients with cystic fibrosis. Chest 1999; 116: 647-54.
14. Florea VG, Florea ND, Sharma R, Coats AJS, Gibson DG, Hodson ME etal. Right ventricular dysfunction in adult severe cystic fibrosis. Chest 2000; 118: 1063-68.
15. Bell SC, Bowerman AM, Nixon LE, Macdonald IA, Elborn JS, Shale DJ. Metabolic and inflammatory responses to pulmonary exacerbations in adults with cystic fibrosis. Eur J Clin Invest 2000; 30: 553-9.
16. Koelling TM, Dec GW, Ginns LC, Semigran MJ. Left ventricular diastolic function in patients with advanced cystic fibrosis. Chest 2003; 123: 1488-94.
17. Fraser KL, Tullis DE, Sasson Z, Hyland RH, Thornley KS, Hanly PJ. Pulmonary hypertension and cardiac function in adult cystic fibrosis* role of hypoxemia. Chest 1999; 115: 1321-8.
18. De Wolf D, Franken P, Piepsz A, Dab I. Left ventricular perfusion deficit in patients with cystic fibrosis. Pediatr Pulmonol 1998; 25: 93-8.
19. Berakis A, Williams TJ, Naughton MT, Martin JH, Muhlmann M, Krum H. Altered sympathetic and parasympathetic activity in lung transplantation patients at rest and following autonomic pertubation. Chest 2002; 122: 1192-9.
20. Floras JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol 1993; 22 (Suppl.): 12A-84A.
21. Knudson R, Lebowitz M, Holberg C, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127: 725-34.
22. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93: 1043-65.
23. Eckberg DL. Human sinus arrhythmia as an index of vagal cardiac outflow. J Appl Physiol 1983; 54: 961-6.
24. Hirsch JA, Bishop B. Respiratory sinus arrhythmia in humans: how breathing pattern modulates heart rate. Am J Physiol Heart Circ Physiol 1981; 241: H620-9.
25. Fouad FM, Tarazi RC, Ferrario CM, Fighaly S, Alicandri C. Assessment of parasympathetic control of heart rate by a noninvasive method. Am J Physiol Heart Circ Physiol 1984; 246: H838-42.
26. Pagani M, Mazzuero G, Ferrari A, Liberati D, Cerutti S, Vaitl D etal. Sympathovagal interaction during mental stress: a study using spectral analysis of heart rate variability in healthy control subjects and patients with a prior myocardial infarction. Circulation 1991; 83: II43-51.
27. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P etal. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986; 59: 178-93.
28. Kingwell B, Thompson J, Kaye D, McPherson G, Jennings G, Esler M. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 1994; 90: 234-40.
29. Tsuji H, Larson MG, Venditti FJ Jr, Manders ES, Evans JC, Feldman CL etal. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996; 94: 2850-5.
30. Mitchell E, Patel H, Wealthall S. Cystic fibrosis heterozygotes have normal autonomic innervation of the heart. Aust Paediatr J 1985; 21: 127-8.
31. Lanza G, Sgueglia G, Cianflone D, Rebuzzi A, Angeloni G, Sestito A etal. Relation of heart rate variability to serum levels of c-reactive protein in patients with unstable angina pectoris. Am J Cardiol 2006; 97: 1702-6.
32. Taha BH, Simon PM, Dempsey JA, Skatrud JB, Iber C. Respiratory sinus arrhythmia in humans: an obligatory role for vagal feedback from the lungs. J Appl Physiol 1995; 78: 638-45.
33. Naughton MT, Floras JS, Rahman MA, Jamal M, Bradley TD. Respiratory correlates of muscle sympathetic activity in heart failure. Clin Sci 1998; 95: 277-85.
34. Coleridge HM, Coleridge JCG. Pulmonary reflexes: neural mechanisms of pulmonary defense. Annu Rev Physiol 1994; 56: 69-91.
35. Koehler DR, Downey GP, Sweezey NB, Tanswell AK, Hu J. Lung inflammation as a therapeutic target in cystic fibrosis. Am J Respir Cell Mol Biol 2004; 31: 377-81.
36. Warren J, Jennings S, Clark T. Effect of adrenergic and vagal blockade on the normal human airway response to exercise. Clin Sci (London) 1984; 66: 79-85.
37. Undem BJ, Kollarik M. The role of vagal afferent nerves in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 355-60.
38. Lewis MJ, Short AL, Lewis KE. Autonomic nervous system control of the cardiovascular and respiratory systems in asthma. Respir Med 2006; 100: 1688-705.